{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T02:04:26Z","timestamp":1782698666464,"version":"3.54.5"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To quantify the placebo effect of various pharmacologic modalities including neuromodulators, hormonal agents, and onabotulinum toxin A for female sexual dysfunction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>DATA SOURCES:<\/jats:title>\n                    <jats:p>Using Meta-analyses Of Observational Studies in Epidemiology guidelines, we conducted a systematic review of PubMed, EMBASE, ClinicalTrials.gov, and the Cochrane Review databases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS OF STUDY SELECTION:<\/jats:title>\n                    <jats:p>Eleven search terms, \u201cfemale sexual dysfunction\u201d \u201ctreatment\u201d in combination with \u201chypoactive sexual desire,\u201d \u201carousal disorder,\u201d \u201csexual pain disorder,\u201d \u201cgenitourinary syndrome of menopause,\u201d \u201corgasmic disorder,\u201d \u201cvulvovaginal atrophy,\u201d \u201cvaginismus,\u201d \u201cvaginal atrophy,\u201d \u201cvulvodynia,\u201d and \u201cvestibulitis,\u201d were used. Studies were included if their design was randomized, included a placebo arm, and used the Female Sexual Function Index as an outcome measure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TABULATION, INTEGRATION, AND RESULTS:<\/jats:title>\n                    <jats:p>The placebo effect on the Female Sexual Function Index was compared with each respective study's treatment effect using inverse-variance weighting in a random-effects analysis model. Six hundred five relevant articles were retrieved. Twenty-four randomized controlled trials included a placebo arm. Of these, eight studies used the Female Sexual Function Index. Across these studies, 1,723 women with clinical pretreatment female sexual dysfunction received placebo. Two thousand two hundred thirty-six women were in the treatment arm of the respective studies and received various pharmacologic interventions including flibanserin, bupropion, onabotulinum toxin A, intravaginal prasterone, intranasal oxytocin, ospemifene, and bremelanotide. Women receiving placebo improved 3.62 (95% CI 3.29\u20133.94) on the Female Sexual Function Index. The treatment arm had a corresponding increase of 5.35 (95% CI 4.13\u20136.57).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>This meta-analysis of Level I evidence demonstrates that 67.7% of the treatment effect for female sexual dysfunction is accounted for by placebo. Our findings suggest that the current treatments for female sexual dysfunction are, overall, minimally superior to placebo, which emphasizes the ongoing need for more efficacious treatment for female sexual dysfunction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000002733","type":"journal-article","created":{"date-parts":[[2018,7,11]],"date-time":"2018-07-11T11:35:16Z","timestamp":1531308916000},"page":"453-458","source":"Crossref","is-referenced-by-count":60,"title":["Female Sexual Dysfunction and the Placebo Effect"],"prefix":"10.1097","volume":"132","author":[{"given":"James M.","family":"Weinberger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin","family":"Houman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley T.","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin N.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi S.","family":"Baskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Lenore","family":"Ackerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karyn S.","family":"Eilber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer T.","family":"Anger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20231015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3109\/13697137.2014.975197","article-title":"Sexual function after fractional microablative CO2 laser in women with vulvovaginal atrophy","volume":"18","author":"Salvatore","year":"2015","journal-title":"Climacteric"},{"key":"R2-20231015","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1258\/ijsa.2008.008336","article-title":"A literature review and case reports series on the use of phosphodiesterase inhibitors in the treatment of female sexual dysfunction","volume":"20","author":"Foster","year":"2009","journal-title":"Int J STD AIDS"},{"key":"R3-20231015","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/jsm.12788","article-title":"Effect of vaginal electrical stimulation on female sexual functions: a randomized study","volume":"12","author":"Aydin","year":"2015","journal-title":"J Sex Med"},{"issue":"suppl A","key":"R4-20231015","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.ghir.2006.03.009","article-title":"Androgen insufficiency in women","volume":"16","author":"Braunstein","year":"2006","journal-title":"Growth Horm IGF Res"},{"key":"R6-20231015","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1743-6109.2012.02941.x","article-title":"Listening to placebo in clinical trials for female sexual dysfunction","volume":"10","author":"Bradford","year":"2013","journal-title":"J Sex Med"},{"key":"R7-20231015","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/152460902317586001","article-title":"Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder","volume":"11","author":"Basson","year":"2002","journal-title":"J Womens Health Gend Based Med"},{"key":"R8-20231015","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1097\/01.ju.0000090966.74607.34","article-title":"Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study","volume":"170","author":"Berman","year":"2003","journal-title":"J Urol"},{"key":"R10-20231015","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/j.jsxm.2016.05.017","article-title":"Diagnosing sexual dysfunction in men and women: sexual history taking and the role of symptom scales and questionnaires","volume":"13","author":"Hatzichristou","year":"2016","journal-title":"J Sex Med"},{"key":"R11-20231015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/00926230590475206","article-title":"The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores","volume":"31","author":"Wiegel","year":"2005","journal-title":"J Sex Marital Ther"},{"key":"R12-20231015","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R13-20231015","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1756-0500-5-52","article-title":"Meta-analyses and forest plots using a microsoft excel spreadsheet: step-by-step guide focusing on descriptive data analysis","volume":"5","author":"Neyeloff","year":"2012","journal-title":"BMC Res Notes"},{"key":"R14-20231015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199701023360101","article-title":"Treatment of men with erectile dysfunction with transurethral alprostadil","volume":"336","author":"Padma-Nathan","year":"1997","journal-title":"N Engl J Med"},{"key":"R15-20231015","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.eururo.2006.02.052","article-title":"Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial","volume":"50","author":"Porst","year":"2006","journal-title":"Eur Urol"},{"key":"R16-20231015","article-title":"Female sexual dysfunction: a systematic review of outcomes across various treatment modalities","author":"Weinberger","year":"2018","journal-title":"Sex Med Rev"},{"key":"R17-20231015","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/713846815","article-title":"Effect of sildenafil on subjective and physiologic parameters of the female sexual response in women with sexual arousal disorder","volume":"27","author":"Berman","year":"2001","journal-title":"J Sex Marital Ther"},{"key":"R18-20231015","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200105243442106","article-title":"Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment","volume":"344","author":"Hr\u00f3bjartsson","year":"2001","journal-title":"N Engl J Med"},{"key":"R19-20231015","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/j.1743-6109.2007.00726.x","article-title":"Tibolone and transdermal E2\/NETA for the treatment of female sexual dysfunction in naturally menopausal women: results of a randomized active-controlled trial","volume":"5","author":"Nijland","year":"2008","journal-title":"J Sex Med"},{"key":"R20-20231015","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/j.1743-6109.2009.01676.x","article-title":"Sexual function and quality of life in women with urinary incontinence treated by a complete pelvic floor rehabilitation program (biofeedback, functional electrical stimulation, pelvic floor muscles exercises, and vaginal cones)","volume":"7","author":"Rivalta","year":"2010","journal-title":"J Sex Med"},{"key":"R21-20231015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/00926230490247093","article-title":"A randomized, placebo-controlled, crossover study of ephedrine for SSRI-induced female sexual dysfunction","volume":"30","author":"Meston","year":"2004","journal-title":"J Sex Marital Ther"},{"key":"R22-20231015","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1067\/mob.2003.117","article-title":"Female sexual dysfunction in postmenopausal women: systematic review of placebo-controlled trials","volume":"188","author":"Modelska","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R23-20231015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1743-6109.2004.04030.x","article-title":"A double-blind randomized placebo control study comparing the objective and subjective changes in female sexual response using sublingual apomorphine","volume":"1","author":"Bechara","year":"2004","journal-title":"J Sex Med"},{"key":"R24-20231015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1176\/appi.ajp.157.2.239","article-title":"Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention","volume":"157","author":"Michelson","year":"2000","journal-title":"Am J Psychiatry"},{"key":"R25-20231015","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2217\/whe-2016-0018","article-title":"Bremelanotide for female sexual dysfunctions in premenopausal women: a randomized, placebo-controlled dose-finding trial","volume":"12","author":"Clayton","year":"2016","journal-title":"Womens Health (Lond)"},{"key":"R26-20231015","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3109\/13697137.2014.954996","article-title":"Female sexual function improved with ospemifene in postmenopausal women with vulvar and vaginal atrophy: results of a randomized, placebo-controlled trial","volume":"18","author":"Constantine","year":"2015","journal-title":"Climacteric"},{"key":"R27-20231015","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1743-6109.2011.02626.x","article-title":"Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study","volume":"9","author":"Derogatis","year":"2012","journal-title":"J Sex Med"},{"key":"R28-20231015","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1111\/jsm.12189","article-title":"Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial","volume":"10","author":"Katz","year":"2013","journal-title":"J Sex Med"},{"key":"R29-20231015","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1111\/jsm.13045","article-title":"Effect of intravaginal prasterone on sexual dysfunction in postmenopausal women with vulvovaginal atrophy","volume":"12","author":"Labrie","year":"2015","journal-title":"J Sex Med"},{"key":"R30-20231015","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.fertnstert.2015.06.010","article-title":"Effect of long-term intranasal oxytocin on sexual dysfunction in premenopausal and postmenopausal women: a randomized trial","volume":"104","author":"Muin","year":"2015","journal-title":"Fertil Steril"},{"key":"R31-20231015","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1111\/j.1743-6109.2009.01378.x","article-title":"Botulinum toxin type A\u2014a novel treatment for provoked vestibulodynia? Results from a randomized, placebo controlled, double blinded study","volume":"6","author":"Petersen","year":"2009","journal-title":"J Sex Med"},{"key":"R32-20231015","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1177\/0269881109351966","article-title":"Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study","volume":"25","author":"Safarinejad","year":"2011","journal-title":"J Psychopharmacol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201808000-00024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,15]],"date-time":"2023-10-15T00:01:07Z","timestamp":1697328067000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201808000-00024"}},"subtitle":["A Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000002733","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733624070.793548373","asserted-by":"object"}]},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]}}}